Order Article Reprints

Biscarini S, Villa S, Genovese C, Tomasello M, Tonizzo A, Fava M, Iannotti N, Bolis M, Mariani B, Valzano AG, et al. Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort Study. Biomedicines. 2022; 10(8):2002. https://doi.org/10.3390/biomedicines10082002

Biscarini, Simona, Simone Villa, Camilla Genovese, Mara Tomasello, Anna Tonizzo, Marco Fava, Nathalie Iannotti, Matteo Bolis, Bianca Mariani, Antonia Grazia Valzano, and et al. 2022. "Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort Study" Biomedicines 10, no. 8: 2002. https://doi.org/10.3390/biomedicines10082002

Biscarini, S., Villa, S., Genovese, C., Tomasello, M., Tonizzo, A., Fava, M., Iannotti, N., Bolis, M., Mariani, B., Valzano, A. G., Morlacchi, L. C., Donato, F., Castellano, G., Cassin, R., Carrabba, M., Muscatello, A., Gori, A., Bandera, A., & Lombardi, A. (2022). Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort Study. Biomedicines, 10(8), 2002. https://doi.org/10.3390/biomedicines10082002